FDA Makes Alzheimer ’s Drug Leqembi Widely Accessible

The F.D.A. gave full approval to the drug, but added a black-box warning about safety risks. Medicare said it would cover most of the high cost.
Source: NYT Health - Category: Consumer Health News Authors: Tags: Drugs (Pharmaceuticals) Alzheimer ' s Disease Medicare Clinical Trials Decisions and Verdicts Memory Biogen Inc Eisai Co Ltd Centers for Medicare and Medicaid Services Food and Drug Administration United States Source Type: news